Matthew Walsh
2021 - Organon & Co.
In 2021, Matthew Walsh earned a total compensation of $6.6M as EVP and Chief Financial Officer at Organon & Co..
Compensation breakdown
| Non-Equity Incentive Plan | $692,160 |
|---|---|
| Option Awards | $2,179,784 |
| Salary | $825,055 |
| Stock Awards | $2,808,152 |
| Other | $53,338 |
| Total | $6,558,489 |
Walsh received $2.8M in stock awards, accounting for 43% of the total pay in 2021.
Walsh also received $692.2K in non-equity incentive plan, $2.2M in option awards, $825.1K in salary and $53.3K in other compensation.
Rankings
In 2021, Matthew Walsh's compensation ranked 1,898th out of 12,405 executives tracked by ExecPay. In other words, Walsh earned more than 84.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,898 out of 12,405 | 85th |
Division Manufacturing | 711 out of 5,494 | 87th |
Major group Chemicals And Allied Products | 267 out of 2,369 | 89th |
Industry group Drugs | 227 out of 2,090 | 89th |
Industry Pharmaceutical Preparations | 154 out of 1,537 | 90th |
Source: SEC filing on April 28, 2022.
Walsh's colleagues
We found four more compensation records of executives who worked with Matthew Walsh at Organon & Co. in 2021.